ClinicalTrials.gov
public full text
Public Domain
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
This study is an open-label extension study in Alzheimer's patients who have completed participation in either solanezumab Clinical Trial H8A-MC-LZAM (NCT00905372) or H8A-MC-LZAN (NCT00904683).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Alzheimer hastalığı olan bireye bakım verenlerin cinsiyetinin bakım veren yükü üzerine etkisi#1038319
- A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease#844223
- A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's#860312
- Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease#1072862
- Multidomain cognitive impairment, along with comorbidities and psychiatric hospitalizations, shorten survival time of patients with Alzheimer's disease dementia: A long term, naturalistic follow-up study.#483338
Record · ID 982294
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive